Lutetium(177 lu)oxodotreotide

Lutathera

Soluzione per infusioneItalyAuthorised

In other countries

The same active substances on other registers, the same brand first.

LutatheraCanada · 370 MBq / ML · Solution · Novartis Pharmaceuticals Canada INCSame brand
LutatheraEuropean Union · Advanced Accelerator ApplicationsSame brand
LutatheraCroatiaSame brand
Lutathera 370 MBq/ml, oplossing voor infusieNetherlands · Oplossing voor infusie · Novartis Europharm LimitedSame brand
Lutathera Solution for Infusion 370 MBQ/MLSingapore · 370 Mbq/ml · injection, solution (radiopharmaceutical) · Novartis (Singapore) Pte LTDSame brand
EndolucinBeta 40 GBq/mL, radiofarmaceutische precursor, oplossingNetherlands · Radiofarmaceutische uitgangsstof · ITM Medical Isotopes GmbHSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Lutetium(177 lu)oxodotreotide

Lutathera

Soluzione per infusioneItalyAuthorised

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ilumira 37 GBq/ml radiofarmaceutische uitgangsstof, oplossingNetherlands · Radiofarmaceutische uitgangsstof · Shine Europe B.V.

Packs

Pack	Code	Status
370 MBQ/ML - SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 20,5 - 25 ML - 1 FLACONCINO	045677010	Autorizzata

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Lutetium(177 lu)oxodotreotide
Dosage form: Soluzione per infusione
Register: Italy (AIFA)
Status: Authorised
Status in the register: Autorizzata
Registration: AIC 045677
Marketing authorisation holder: Novartis Europharm Limited
ATC code: V10XX04
Group: Various
Procedure: Procedura Centralizzata
Supply: Medicinali soggetti a prescrizione medica limitativa, utilizzabili esclusivamente in ambiente ospedaliero o in una struttura ad esso assimilabile